MannKind (Clinical Program Rights)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Colby Pharmaceutical
Primary Office
- 25134 Rye Canyon Loop
- Suite 300
- Valencia, CA 91355
- United States
MannKind (Clinical Program Rights) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore MannKind (Clinical Program Rights)‘s full profile, request access.
Request full access to PitchBookMannKind (Clinical Program Rights) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore MannKind (Clinical Program Rights)‘s full profile, request access.
Request full access to PitchBook